Your browser doesn't support javascript.
loading
Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19.
Solanich, Xavier; Vargas-Parra, Gardenia; van der Made, Caspar I; Simons, Annet; Schuurs-Hoeijmakers, Janneke; Antolí, Arnau; Del Valle, Jesús; Rocamora-Blanch, Gemma; Setién, Fernando; Esteller, Manel; van Reijmersdal, Simon V; Riera-Mestre, Antoni; Sabater-Riera, Joan; Capellá, Gabriel; van de Veerdonk, Frank L; van der Hoven, Ben; Corbella, Xavier; Hoischen, Alexander; Lázaro, Conxi.
Afiliación
  • Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Vargas-Parra G; Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • van der Made CI; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Simons A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Schuurs-Hoeijmakers J; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands.
  • Antolí A; Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, Netherlands.
  • Del Valle J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Rocamora-Blanch G; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Setién F; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Esteller M; Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • van Reijmersdal SV; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Riera-Mestre A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sabater-Riera J; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
  • Capellá G; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • van de Veerdonk FL; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
  • van der Hoven B; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Corbella X; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
  • Hoischen A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Lázaro C; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Front Immunol ; 12: 719115, 2021.
Article en En | MEDLINE | ID: mdl-34367187
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mutación Missense / Receptor Toll-Like 7 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mutación Missense / Receptor Toll-Like 7 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza